Vistagen Therapeutics Inc —— 资产负债表 (NASDAQ:VTGN) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 108.28 M74.64 M21.09 M123.65 M84.34 M 负债总额 16.3 M9.93 M9.01 M9.37 M13.95 M 权益总额 91.98 M64.72 M12.08 M114.29 M70.39 M 负债及股东权益总额 108.28 M74.64 M21.09 M123.65 M84.34 M 总债务 ————— 净债务 —————

新闻

Vistagen Therapeutics裁员20%以控制成本

Vistagen Therapeutics reduces workforce by 20 percent to manage costs

VistaGen在TD Cowen大会上展示:聚焦信息素平台技术

VistaGen at TD Cowen Conference: Pherine Platform in Focus

Vistagen Therapeutics, Inc. (VTGN) Q3 2026 Earnings Call Transcript

VistaGen Therapeutics 2026年第三季度财报电话会议：AI驱动的试验分析亮点

Earnings call transcript: VistaGen Therapeutics Q3 2026 highlights AI-driven trial analysis

VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Lags Revenue Estimates

Vistagen Therapeutics公司的fasedienol三期临床试验未达终点

Vistagen Therapeutics reports Phase 3 trial for fasedienol did not meet endpoint

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47%

美国股市收低；截至收盘道琼斯工业平均指数下跌0.47%